Carerx Corporation · TSX:CRRX

Carerx — Centric Health — Q2 2019 Earnings Presentation

12 slides from Carerx's earnings presentation, Aug 15, 2019

  1. Slide 1: Q2 2019 Earnings Call

    Q2 2019 Earnings Call August 15, 2019

  2. Slide 2: Forward Looking Statements

    Forward Looking Statements Certain of the statements contained in this presentation are "forward-looking information“ within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, business strategy, plans and other expectations, belief

  3. Slide 3: David Murphy, President & Chief Executive Officer

    David Murphy President & Chief Executive Officer

  4. Slide 4: Second Quarter Highlights

    Second Quarter Highlights % growth in Adjusted EBITDA 50.5 from Specialty Pharmacy  Adjusted EBITDA margin of 11.8%  Specialty Pharmacy revenue increased 6.5%  Average number of beds serviced up 9.6% to 31,265 4

  5. Slide 5: Continued Growth in Number of Beds Serviced

    Continued Growth in Number of Beds Serviced 31,265  Increased average beds 30,341 serviced by more than 2,728 29,690 compared to Q2 2018 29,040  Average beds serviced up 3% since Q1 2019 28,537 Average number of beds serviced Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 5

  6. Slide 6: Sale of Surgical and Medical Centres Division

    Sale of Surgical and Medical Centres Division  Signed definitive agreement with Kensington Capital Advisors on August 9, 2019  Cash purchase price of $35M  Expected to close Sept. 30, 2019  Net proceeds will be used to pay down debt 6

  7. Slide 7: Continuing to Improve our Balance Sheet

    Continuing to Improve our Balance Sheet $51.4 million aggregate proceeds YTD  Divestiture of  Private placement non-core assets equity raise

  8. Slide 8: Multiple Growth Opportunities

    Multiple Growth Opportunities Increase our customer base Add more beds under care; Penetrate seniors living at home market Expand scope of services Leverage national platform / existing customer base; Examples: medical cannabis, medical supplies Consolidate the market Make accretive acquisitions res

  9. Slide 9: Andrew Mok, Interim Chief Financial Officer

    Andrew Mok Interim Chief Financial Officer

  10. Slide 10: Specialty Pharmacy Quarterly Results

    Specialty Pharmacy Quarterly Results Revenue  Revenue of $31.5 million in Q2 ($ millions) 2019 32  Up 6.5% from $29.6 million in 24 Q2 2018 16  Increase due to higher average number of beds serviced & 8 impact of Business Re-Engineering Plan 0 Q2 2018 Q2 2019 10

  11. Slide 11: Specialty Pharmacy Quarterly Results

    Specialty Pharmacy Quarterly Results Adjusted EBITDA  Adjusted EBITDA of $3.7 ($ millions) million 4  Up 50.5% from Q2 2018 3  Adjusted EBITDA Margin = 2 11.8% vs 8.3% in Q2 2018 1  Third consecutive quarter of sequential profit growth 0 Q2 2018 Q3 2018 Q4 2018 Q1 2019 Q2 2019 11

  12. Slide 12: Investor Relations

    INVESTOR RELATIONS Trevor Heisler NATIONAL Capital Markets 416-848-1434 theisler@national.ca

Centric Health — Q2 2019 Earnings Presentation on 6ix